Global Hypoxia Market Companies

Pharmaceutical
Nov 2024
Global
350 Pages
No of Tables: 220
No of Figures: 60

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Hypoxia Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

Who are major players in hypoxia market?

Companies such Thermo Fisher Scientific Inc. (U.S.) , F. Hoffmann-La Roche Ltd (Switzerland) , Merck KGaA (Germany), CASI Pharmaceuticals, Inc. (U.S.) and Spotlight Labs, LLC. (U.S.) are major players in hypoxia market.

What are the recent product launches by major companies in the hypoxia market?

In August 2023, Merck received FDA approval for WELIREG (belzutifan), a hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of certain tumors associated with Von Hippel-Lindau (VHL) disease. This approval highlights the therapeutic potential of targeting hypoxia-related pathways in cancer treatment, offering a new option for patients with this rare genetic condition

Which countries data is covered in the hypoxia market?

The countries covered in the hypoxia market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.